Baxter Debt Issuance/Retirement Net - Total 2010-2025 | BAX

Baxter annual/quarterly debt issuance/retirement net - total history and growth rate from 2010 to 2025. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
  • Baxter debt issuance/retirement net - total for the quarter ending June 30, 2025 was $-3.125B, a 20733.33% increase year-over-year.
  • Baxter debt issuance/retirement net - total for the twelve months ending June 30, 2025 was $-5.307B, a 61.7% increase year-over-year.
  • Baxter annual debt issuance/retirement net - total for 2024 was $-0.531B, a 81.91% decline from 2023.
  • Baxter annual debt issuance/retirement net - total for 2023 was $-2.935B, a 226.47% increase from 2022.
  • Baxter annual debt issuance/retirement net - total for 2022 was $-0.899B, a 109.64% decline from 2021.
Baxter Annual Debt Issuance/Retirement Net - Total
(Millions of US $)
2024 $-531
2023 $-2,935
2022 $-899
2021 $9,326
2020 $478
2019 $1,883
2018 $N/A
2017 $665
2016 $-40
2015 $2,507
2014 $-113
2013 $3,096
2012 $765
2011 $733
2010 $91
2009 $473
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $11.167B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $219.550B 25.75
Boston Scientific (BSX) United States $155.224B 37.07
Stryker (SYK) United States $149.901B 30.56
EssilorLuxottica (ESLOY) France $137.930B 0.00
Medtronic (MDT) Ireland $115.737B 16.41
Lonza Group Ag (LZAGY) Switzerland $48.985B 0.00
Haleon (HLN) United Kingdom $42.363B 24.18
ResMed (RMD) United States $39.874B 28.48
Agilent Technologies (A) United States $32.613B 21.26
GE HealthCare Technologies (GEHC) United States $32.562B 15.31
Koninklijke Philips (PHG) Netherlands $25.229B 16.69
Terumo (TRUMY) Japan $25.051B 32.54
Insulet (PODD) United States $20.296B 79.67
Zimmer Biomet Holdings (ZBH) United States $18.133B 11.65
Smith & Nephew SNATS (SNN) United Kingdom $13.385B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.584B 24.05
Lantheus Holdings (LNTH) United States $4.925B 12.42
Perrigo (PRGO) Ireland $3.667B 9.29
Prestige Consumer Healthcare (PBH) United States $3.654B 16.33
Haemonetics (HAE) United States $3.557B 16.20
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.202B 21.97
ICU Medical (ICUI) United States $3.160B 23.31
LeMaitre Vascular (LMAT) United States $1.836B 41.03
AtriCure (ATRC) United States $1.745B 0.00
QuidelOrtho (QDEL) United States $1.557B 10.71
Acuren (TIC) United States $1.347B 0.00
Green Thumb Industries (GTBIF) United States $1.251B 28.14
AdaptHealth (AHCO) United States $1.210B 12.29
Phibro Animal Health (PAHC) United States $1.074B 13.73
BioLife Solutions (BLFS) United States $1.017B 0.00
Neogen (NEOG) United States $1.010B 16.03
Curaleaf Holdings (CURLF) Canada $0.905B 0.00
InMode (INMD) Israel $0.863B 7.99
Kestra Medical Technologies (KMTS) United States $0.847B 0.00
Valneva SE (VALN) France $0.625B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.596B 0.00
Tilray Brands (TLRY) Canada $0.585B 0.00
Evolus (EOLS) United States $0.575B 0.00
Owens & Minor (OMI) United States $0.535B 4.44
ZimVie (ZIMV) United States $0.523B 20.42
CeriBell (CBLL) United States $0.520B 0.00
Surmodics (SRDX) United States $0.513B 0.00
SNDL (SNDL) Canada $0.452B 0.00
Capricor Therapeutics (CAPR) United States $0.374B 0.00
Sanuwave Health (SNWV) United States $0.330B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
VAREX IMAGING (VREX) United States $0.300B 11.03
Quanterix (QTRX) United States $0.297B 0.00
Cresco Labs (CRLBF) United States $0.291B 0.00
Aurora Cannabis (ACB) Canada $0.249B 73.83
Cerus (CERS) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.241B 20.30
Omeros (OMER) United States $0.239B 0.00
OraSure Technologies (OSUR) United States $0.238B 0.00
Biote (BTMD) United States $0.223B 6.26
Brainsway (BWAY) Israel $0.221B 58.40
Sanara MedTech (SMTI) United States $0.215B 0.00
Canopy Growth (CGC) Canada $0.211B 0.00
Verano Holdings (VRNOF) United States $0.205B 0.00
Exagen (XGN) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.181B 14.87
Organigram Global (OGI) Canada $0.180B 0.00
High Tide (HITI) Canada $0.178B 0.00
Vireo Growth (VREOF) United States $0.176B 0.00
TriSalus Life Sciences (TLSI) United States $0.160B 0.00
TerrAscend (TSNDF) Canada $0.124B 0.00
FitLife Brands (FTLF) United States $0.117B 14.45
Jushi Holdings (JUSHF) United States $0.111B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
MacroGenics (MGNX) United States $0.098B 0.00
Fonar (FONR) United States $0.097B 12.49
Quipt Home Medical (QIPT) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Apyx Medical (APYX) United States $0.072B 0.00
Veru (VERU) United States $0.071B 0.00
Zynex (ZYXI) United States $0.067B 0.00
Agape ATP (ATPC) $0.064B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Nephros (NEPH) United States $0.038B 50.71
United-Guardian (UG) United States $0.036B 12.38
Rockwell Medical (RMTI) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00